STUART P MILLER, MD
Medical Practice at Sheridan Rd, Melbourne, FL
License number
Florida ME0049094
Category
Medical Practice
Type
Specialist
Address
Address
301 Sheridan Rd, Melbourne, FL 32901
Phone
(321) 951-8137
(321) 951-8138 (Fax)
(321) 951-8138 (Fax)
Personal information
See more information about STUART P MILLER at radaris.comName
Address
Phone
4701 Grapevine Way, Davie, FL 33331
471 Bermuda Dr, Lake Wales, FL 33859
4300 SE Saint Lucie Blvd, Stuart, FL 34997
502 Royal Wood Ct, Valrico, FL 33594
5303 N Mendenhall Dr, Tampa, FL 33603
Organization information
See more information about STUART P MILLER at bizstanding.comBrevard Rehabilitation MDCN - Stuart P Miller MD
101 E Florida Ave, Melbourne, FL 32901
Categories:
Medical Research & Development, Physicians & Surgeons, Sports Medicine Physicians & Surgeons
Phone:
(321) 951-8137 (Phone)
Specialties:
Physical Medicine, Physical Rehabilitation
STUART P. MILLER, M.D., INC
Melbourne, FL
Status:
Inactive
Inactive reason:
Amendment And Name Change
Registration:
Nov 7, 2003
Inactive since:
Jun 9, 2011
Addresses:
301 E Sheridan Rd, Melbourne, FL 32901 (Physical)
101 E Florida Ave, Melbourne, FL 32901
101 E Florida Ave, Melbourne, FL 32901
State ID:
P03000128714
Business type:
Florida Profit Corporation
Directors:
Md Miller, 301 E Sheridan Rd, Melbourne, FL 32901 (Physical),Stuart P. Miller (Director)
Agent:
John Kancilia,1795 W Nasa Blvd, Melbourne, FL 32901 (Physical)
EIN:
32-0100083
Professional information
Stimulation Of Nociceptor (Irritant) And C-Fibre Receptors In Patients Throat By Nebulized Application Of Chemostimulant And Contrast Material That Allows Fluoroscopy Observation Of Larynx Response For Identifying Patients Risk To Dysphagia
US Patent:
6568397, May 27, 2003
Filed:
Mar 1, 2001
Appl. No.:
09/797196
Inventors:
W. Robert Addington - Melbourne Beach FL
Robert E. Stephens - Kansas City MO
Stuart P. Miller - Melbourne Beach FL
Robert E. Stephens - Kansas City MO
Stuart P. Miller - Melbourne Beach FL
Assignee:
Pneumoflex Systems L.L.C. - Melbourne FL
International Classification:
A61B 508
US Classification:
128897, 600529
Abstract:
The injection of an aerosol containing a chemostimulant into a patients throat to stimulate nociceptor (irritant) and c-fibre receptors is augmented by the inclusion of a medically safe and accepted contrast substance, such as barium. The addition of a contrast substance to the aerosol allows fluoroscopic observation of the patients (larynx) response, to facilitate a medical practitioners identification of whether the patient is at risk to one or more abnormal physiological conditions, such as oral or pharyngeal dysphagia, and pneumonia.
Pediatric Nebulizer
US Patent:
2012019, Jul 26, 2012
Filed:
Jan 19, 2012
Appl. No.:
13/353657
Inventors:
W. Robert Addington - Melbourne Beach FL, US
Stuart P. Miller - Indialantic FL, US
Robert E. Stephens - Parkville MO, US
Stuart P. Miller - Indialantic FL, US
Robert E. Stephens - Parkville MO, US
Assignee:
PNEUMOFLEX SYSTEMS, LLC - Melbourne FL
International Classification:
A61M 11/02, A61B 5/087, A61J 17/00
US Classification:
600538, 12820021
Abstract:
A nebulizer includes a body having an air channel section, medication reservoir and nebulizer outlet configured to be received within an oral cavity of a patient. A nebulizer suction member encloses the body and is configured as an infant pacifier. An air line extends through the air channel section and has a venturi nozzle and at its end configured to form a low pressure mixing chamber. A primary suction line extends from the medication reservoir to the low pressure mixing chamber through which medication is drawn upward and mixed with air passing through the venturi nozzle and nebulized for discharge through the nebulizer outlet.
Involuntary Contraction Induced Pressure As A Medical Diagnostic Tool Using Involuntary Reflex Cough Test
US Patent:
2013030, Nov 14, 2013
Filed:
Jul 16, 2013
Appl. No.:
13/943163
Inventors:
Stuart P. MILLER - Indialantic FL, US
Robert E. Stephens - Parkville MO, US
Michael M. PHELIPA - Melbourne FL, US
Mary W. BRIGANTI - Melbourne FL, US
Robert E. Stephens - Parkville MO, US
Michael M. PHELIPA - Melbourne FL, US
Mary W. BRIGANTI - Melbourne FL, US
International Classification:
A61B 5/20, A61B 5/145, A61B 5/01
US Classification:
600301, 600549, 600561, 600361, 600300, 600367, 600309
Abstract:
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
Techniques For Evaluating Stress Urinary Incontinence (Sui) Using Involuntary Reflex Cough Test
US Patent:
8602987, Dec 10, 2013
Filed:
Dec 21, 2009
Appl. No.:
12/643251
Inventors:
W. Robert Addington - Melbourne Beach FL, US
Robert E. Stephens - Parkville MO, US
Michael M. Phelipa - Melbourne FL, US
Mary W. Briganti - Melbourne FL, US
Stuart P. Miller - Melbourne Beach FL, US
Robert E. Stephens - Parkville MO, US
Michael M. Phelipa - Melbourne FL, US
Mary W. Briganti - Melbourne FL, US
Stuart P. Miller - Melbourne Beach FL, US
Assignee:
Pneumoflex Systems, LLC - Melbourne FL
International Classification:
A61B 5/00
US Classification:
600301, 600546, 600561
Abstract:
A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
Aspiration Screening Process For Assessing Need For Modified Barium Swallow Study
US Patent:
2001000, Jun 7, 2001
Filed:
Dec 12, 2000
Appl. No.:
09/734404
Inventors:
W. Addington - Indialantic FL, US
Stuart Miller - Melbourne Beach FL, US
Roben Ockey - San Antonio TX, US
Robert Stephens - Parkville MO, US
Stuart Miller - Melbourne Beach FL, US
Roben Ockey - San Antonio TX, US
Robert Stephens - Parkville MO, US
International Classification:
A61B005/08
US Classification:
600/529000, 128/898000
Abstract:
Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time. If the patient is able to hold a prescribed volume of water in the patient's mouth for the prescribed period of time, the patient is permitted to be given a modified barium swallow test. If the patient is unable to hold a prescribed volume of water in the patient's mouth for the prescribed period of time, the patient is not permitted to be given a modified barium swallow test.
Involuntary Contraction Induced Pressure As A Medical Diagnostic Tool Using Involuntary Reflex Cough Test
US Patent:
8597183, Dec 3, 2013
Filed:
Dec 21, 2009
Appl. No.:
12/643134
Inventors:
W. Robert Addington - Melbourne Beach FL, US
Robert E. Stephens - Parkville MO, US
Michael M. Phelipa - Melbourne FL, US
Mary W. Briganti - Melbourne FL, US
Stuart P. Miller - Melbourne Beach FL, US
Robert E. Stephens - Parkville MO, US
Michael M. Phelipa - Melbourne FL, US
Mary W. Briganti - Melbourne FL, US
Stuart P. Miller - Melbourne Beach FL, US
Assignee:
Pneumoflex Systems, LLC - Melbourne FL
International Classification:
A61B 5/00
US Classification:
600301, 600546, 600561
Abstract:
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
Involuntary Contraction Induced Pressure As A Medical Diagnostic Tool Using Involuntary Reflex Cough Test
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 22, 2013
Appl. No.:
14/059901
Inventors:
STUART P. MILLER - INDIALANTIC FL, US
ROBERT E. STEPHENS - PARKVILLE MO, US
MICHAEL M. PHELIPA - MELBOURNE FL, US
MARY W. BRIGANTI - MELBOURNE FL, US
ROBERT E. STEPHENS - PARKVILLE MO, US
MICHAEL M. PHELIPA - MELBOURNE FL, US
MARY W. BRIGANTI - MELBOURNE FL, US
Assignee:
PNEUMOFLEX SYSTEMS, LLC - MELBOURNE FL
International Classification:
A61B 5/20, A61B 5/00, A61M 15/00, A61B 5/04, A61B 5/0488, A61B 5/08
US Classification:
600301, 600546
Abstract:
A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
System And Method Of Testing The Gastric Valve And Urethral Sphincter
US Patent:
2012027, Nov 1, 2012
Filed:
Apr 26, 2012
Appl. No.:
13/456841
Inventors:
W. Robert ADDINGTON - Melbourne Beach FL, US
Stuart P. Miller - Indialantic FL, US
Robert E. Stephens - Parkville MO, US
Stuart P. Miller - Indialantic FL, US
Robert E. Stephens - Parkville MO, US
Assignee:
PNEUMOFLEX SYSTEMS, LLC - MELBOURNE FL
International Classification:
A61B 6/00, A61B 5/00, A61B 5/20, A61B 5/0488
US Classification:
600301
Abstract:
A system and method tests the gastric valve and urethral sphincter in a patient. A contrast agent is administered into the esophagus of a patient followed by inducing an involuntary reflex cough epoch within the patient to isolate the gastric valve from the lower esophageal sphincter (LES) and isolate the external urethral sphincter from the internal urethral sphincter. An imaging sensor detects the flow of the contrast agent during the involuntary reflex cough epoch and determines whether stomach reflux occurred indicative of a malfunctioning gastric valve. A determination is made if urine leakage occurs indicative of stress urinary incontinence (SUI).
Intra-Oral Nebulizer With Rainfall Chamber
US Patent:
7726306, Jun 1, 2010
Filed:
Nov 9, 2006
Appl. No.:
11/557993
Inventors:
W. Robert Addington - Melbourne Beach FL, US
Stuart Miller - Indialantic FL, US
Mary Briganti - Melbourne FL, US
Stuart Miller - Indialantic FL, US
Mary Briganti - Melbourne FL, US
Assignee:
Pneumoflex Systems, LLC - Melbourne FL
International Classification:
A61M 15/00
US Classification:
12820312
Abstract:
An improved nebulizer places a venturi in a rainfall chamber and in close proximity to or inside a patient's oral cavity. One or more medicine feed lines feeds the medicine to a location proximate to a venturi. The rainfall chamber contains a sump communicating with the venturi for collecting medication not delivered to the patient and for recycling that medication for delivery to the patient. A medicine receiver may be pre-filled with a standard unit dose of medication.
Techniques For Evaluating Urinary Stress Incontinence
US Patent:
2007025, Nov 1, 2007
Filed:
Oct 17, 2006
Appl. No.:
11/550125
Inventors:
W. Addington - Melbourne Beach FL, US
Stuart Miller - Indialantic FL, US
Robert Stephens - Kansas City MO, US
Stuart Miller - Indialantic FL, US
Robert Stephens - Kansas City MO, US
International Classification:
A61F 2/00
US Classification:
600029000
Abstract:
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.